VIVO Cannabis Inc. announced the launch of Beacon MedicalTM Extra Strength CBD|T Cream, an innovative, premium cannabis topical cream for Canadian medical patients. With 500 mg of cannabidiol (CBD) per 50-gram unit, in a proprietary formulation that includes carefully curated ingredients with anti-oxidant, anti-inflammatory, and analgesic properties, together with skin penetration enhancers, Beacon MedicalTM Extra Strength CBD|T Cream is designed using "entourage" principles to achieve synergies of bioactive ingredients and provide optimal symptom relief for medical conditions. The proprietary Beacon MedicalTM Extra Strength CBD|T Cream formula is the only topical cannabinoid formulation to combine CBD extract with the skin bioactive terpenes bisabolol and terpineol, in addition to menthol, peppermint oil and eucalyptus oil. The Beacon MedicalTM formulation also uniquely includes coconut and moringa oils, together with other premium ingredients including aloe, beeswax, shea butter, jojoba esters and vitamin E. It is designed to provide fast-acting symptom relief. The Beacon MedicalTM Extra Strength CBD|T Cream does not contain acrylamides, parabens, parfum, phenoxyethanol, silicon-based polymers, and sodium hydroxide - potential harmful or skin irritating ingredients found in other cannabis topical products on the market. Beacon MedicalTM Extra Strength CBD|T Cream has a mild, minty scent, provides a cooling sensation to the skin, and is packaged in 50 gram jars that preserve freshness. Beacon MedicalTM Extra Strength CBD|T Cream is available to order now through the Canna Farms e- commerce medical marketplace for Canadian medical patients. A second Beacon MedicalTM Extra Strength BAL|T Cream will be available in the coming weeks with 250 mg of tetrahydrocannabinol (THC) and 250 mg of CBD per 50-gram unit. VIVO plans to expand its topical offerings later this year under the LuminaTM brand for health & wellness consumers.